Brand name (Generic drug name)

EMGALITY

Active Ingredient: galcanezumab

Drug Class: Anti-Calcitonin gene-related peptide receptors

EMGALITY is not covered on the Reformulary. Reformulary covers two preferred drugs in the CGRP antagonist class of drugs: AJOVY (fremanezumab) and VYEPTI (eptinezumab). Both drugs require Special Authorization.
 

EMGALITY is used to treat  
Migraines